couter

ALGEN.PAgenOway S.A.

Nov 12, 2026 — Dilution & Capital Restructuring Window
Chart by TradingView

The schedule

  • Thu12Nov

    Critical window for a potential equity raise or debt restructuring to service the $13.7M debt load.

  • Wed20Jan

    Anticipated announcement regarding new pharmaceutical co-development or licensing deals utilizing genOway's model organism platforms.

  • Sun31Jan
  • Wed24Mar

    Full-year 2026 results evaluating whether the company has successfully integrated its capacity expansions into recurring revenue streams.

  • Sun2May
  • Tue15Jun

    Sector-wide multiple expansion as risk appetite for European micro-cap life science tools improves.

  • Sun1Aug
  • Sun31Oct

Past

  • Thu24Sep

    Release of semi-annual H1 2026 results, focusing heavily on operating cash burn versus the reported 5.96% YoY revenue growth.